Parameter | Urothelial carcinoma | Non-neoplastic urinary tract disease | Healthy control dogs | P value†|
---|---|---|---|---|
Total number of dogs | 22 | 26 | 7 | – |
 analyzed by IHC | 9 | 5 | 6 | |
 in NLR analysis | 21 | 26 | 1 | |
Age†,*, in years | 11.2A | 6.6B | 6.5a,B | 0.0001 |
 median [range] | [6.8–14.3] | [0.3–14.5] | [2.0–10.0] | |
Weight, in kg | 26.0 | 14.5 | 21.8 | 0.5074 |
 median [range] | [6.2–49.0] | [3.0–54.0] | [5.2–41.5] | |
Sex | ||||
 male (n) / female (sp) | 4 (2) / 18 (6) | 20 (5) / 6 (4) | 7 (2) /0 (0) | < 0.0001 |
Breed | ||||
 pure-bred | 12 (55%) | 21 (81%) | 5 (71%) | 0.1450 |
 mixed breed | 10 (45%) | 5 (19%) | 2 (29%) | |
Biopsy typeb | ||||
 endoscopic | 9 (90%) | 3 (43%) | 1 (14%) | – |
 surgical | 0 | 4 (57%) | 0 | |
 post-mortem | 1 (10%) | 0 | 6 (86%) | |
Primary disease locationb | ||||
 urethra | 4 (40%) | 1 (20%) | – | – |
 urinary bladder | 6 (60%) | 4 (80%) | ||
Tissues evaluatedb | ||||
 urethra | 5 (50%) | 1 (17%) | 5 (71%) | – |
 urinary bladder | 6 (60%) | 6 (83%) | 7 (100%) | |
Treatment | ||||
 treatment-naïve | 8 (36%) | 19 (79%)c | – | – |
 NSAID treatment | 14 (64%) | 5 (21%)c | ||
Urine culture | ||||
 positive | 3 (25%)d | 8 (44%)e | – | – |
 negative | 9 (75%)d | 10 (56%)e |